MeiraGTx Holdings plc
NASDAQ:MGTXBiotechnology
+$0.53 today
- Market cap
- $813.12M
- Beta
- 1.26
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$1.48
Volume 0.58M
Average 0.84M
MGTX Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
MeiraGTx Holdings plcNASDAQ: MGTX
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses turns negative
Q1 FY2026 other income / expenses was -$5.5M, compared with $1.62M a year earlier. Trailing-twelve-month other income / expenses was -$15.34M.
Context
- Other income / expenses amounted to 10.1% of revenue in FY2025, down 39.2 pp from a year earlier.
- Other income / expenses increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly other income / expenses holds near -$5.5M or moves back toward the trailing-twelve-month quarterly average of -$3.84M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (8.23M) USD
- Year-over-year change
- -150.1%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (8.23M) | -150.1% |
| FY2024 | 2024-12-31 | 16.42M | -69.0% |
| FY2023 | 2023-12-31 | 53.03M | +500.0% |
| FY2022 | 2022-12-31 | (13.26M) | -94.9% |
| FY2021 | 2021-12-31 | (6.8M) | — |
Other Income / Expenses vs competitors
How MGTX compares with its peers on the latest reported figures
- MGTX's LTM Mar 2026 other income / expenses of -$15.34M is the 7th highest of the 9 companies compared; the peer median is -$4.92M.
- Its year-over-year change of -85.0% is the 5th highest of 9, against a peer median of -121.3%.
- Other income / expenses amounts to 19.2% of revenue for MGTX, versus a peer median of 39.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $28.7M | -2.6% | +75.4% | 6.5% | |
| LTM Mar 2026 | $26.12M | +72.4% | — | 39.5% | |
| LTM Mar 2026 | $18.65M | -30.6% | +97.1% | 21.1% | |
| LTM Mar 2026 | -$4.43M | -212.0% | — | — | |
| LTM Mar 2026 | -$5.42M | -1137.2% | — | 121.4% | |
| LTM Mar 2026 | -$11.92M | +74.0% | — | 65.9% | |
| LTM Mar 2026 | -$15.34M | -85.0% | — | 19.2% | |
| LTM Mar 2026 | -$31.59M | -712.7% | — | 213.7% | |
| LTM Mar 2026 | -$33.33M | -9907.5% | — | 37.9% | |
| Peer median (excluding MGTX) | -$4.92M | -121.3% | +86.3% | 39.5% | |
Competitors are the stored peer set for MGTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 37.7M | 15.92M | 14.02M | 33.28M | 81.39M |
| Cost of Revenue | 0 | 0 | 0 | 23.79M | 4.84M |
| Gross Profit | 37.7M | 15.92M | 14.02M | 9.49M | 76.55M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 28.5% | 94.0% |
| Research & Development | 66.69M | 85.73M | 103.79M | 119.48M | 129.62M |
| Selling, General & Admin | 43.77M | 46.55M | 47.29M | 54.22M | 52.9M |
| Operating Expenses | 110.46M | 132.28M | 151.08M | 173.7M | 182.52M |
| Depreciation & Amortization | 7.87M | 8.6M | 13.73M | 12.83M | 12.61M |
| EBITDA | (71.4M) | (116.07M) | (57.05M) | (121.69M) | (89.4M) |
| EBITDA Margin | -189.4% | -729.1% | -407.0% | -365.7% | -109.8% |
| Operating Income | (72.76M) | (116.36M) | (137.06M) | (164.21M) | (105.97M) |
| Operating Margin | -193.0% | -730.9% | -977.8% | -493.4% | -130.2% |
| Interest Income | 212K | 777K | 2.27M | 4.15M | 1.82M |
| Interest Expense | 288K | 4.95M | 13.25M | 13.27M | 12.2M |
| Other Income / Expenses | (6.8M) | (13.26M) | 53.03M | 16.42M | (8.23M) |
| Income Before Tax | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Pre-Tax Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (79.56M) | (129.62M) | (84.03M) | (147.79M) | (114.2M) |
| Net Margin | -211.0% | -814.2% | -599.5% | -444.1% | -140.3% |
| EPS (Basic) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| EPS (Diluted) | (1.80) | (2.87) | (1.49) | (2.12) | (1.42) |
| Weighted Avg Shares | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
| Weighted Avg Shares (Diluted) | 44.14M | 45.18M | 56.49M | 69.82M | 80.43M |
MeiraGTx Holdings plc
NASDAQ:MGTX
Intrinsic Alpha fair value
Locked
Current Price
$8.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.